Chongbo Sun

Institute of Cancer Research

Papers

1

Total Citations

16

H-Index

1

About

Chongbo Sun is a distinguished researcher in chemical biology and drug discovery, with a primary focus on kinase inhibitor development and high-throughput screening methodologies. Their most cited work, "High-Throughput Screening Assay for Identification of Small Molecule Inhibitors of Aurora2/STK15 Kinase" (2004), has garnered 16 citations, establishing a foundational approach for targeting Aurora kinases—key regulators of mitosis implicated in cancer progression. This contribution exemplifies Sun’s expertise in designing robust assay systems that accelerate the identification of therapeutic leads, bridging the gap between basic kinase biology and translational medicine. While their publication record reflects a targeted impact in early-stage drug discovery, Sun’s work has informed subsequent studies on cell cycle checkpoints and oncology targets. Their methodological innovations in high-throughput screening continue to serve as a valuable resource for researchers seeking to develop selective kinase inhibitors, underscoring a career dedicated to advancing preclinical tools for precision cancer therapeutics.

Research Focus

Key Achievements

1
H-Index
1
Papers
16
Total Citations
16
Avg Citations/Paper
🏆 Most Cited Paper
High-Throughput Screening Assay for Identification of Small Molecule Inhibitors of Aurora2/STK15 Kinase
16 citations · 2004
📈 Most Prolific Year: 2004 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Institute of Cancer Research

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago